- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07147985
- Original Trial
Effects of Different Exercises on Energy Metabolism and Muscle Activation in Normal-Weight and Overweight Students
This clinical trial aims to investigate the effects of different exercise modalities on energy metabolism and muscle activation in both normal-weight and overweight university students.
The main question it aims to answer is:
Compared to normal-weight university students, does slow jogging at different step frequencies reduce body weight and increase energy expenditure (and metabolic rate) in overweight university students? Compared to normal-weight university students, does slow jogging at different step frequencies enhance muscle activation effects in overweight university students?
Researchers will compare three distinct step frequencies during slow jogging (162, 180, and 198 steps per minute) to determine which exercise modality is potentially more effective for increasing energy expenditure and metabolic rate.
Participants will:
Participants will sequentially undergo three separate testing sessions, each involving ultra-slow running at one of the three step frequencies (162, 180, or 198 steps per minute).
Testing sessions will occur once per week in the laboratory.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Shanxi
-
Taiyuan, Shanxi, China, 030031
- Shanxi Normal University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Aged 18 to 23 years old;
- BMI between 24.0 kg/m² and 27.9 kg/m² ;
- No participation in any structured weight loss or weight control interventions (including exercise programs, pharmacological agents, or dietary regimens) within the preceding three months;
- Cleared for exercise participation with no identified risks, as determined by the Physical Activity Readiness Questionnaire (PAR-Q);
- Willing and able to comply fully with the experimental protocol, including completion of all training sessions and required measurements;
- Provision of written informed consent.
Exclusion Criteria:
- History of psychiatric disorders, diabetes mellitus, heart disease, hypertension, anemia, or any other contraindications to exercise (e.g., dizziness, chest pain, shortness of breath);
- Immune dysfunction or severe hepatic or renal insufficiency;
- Unhealthy habits, such as regular smoking or excessive alcohol consumption;
- Current use of prescription medication (excluding contraceptives or incidental short-term medications, if specified and approved by the study investigators);
- Coagulation disorders or a significant bleeding tendency.
Withdrawal and Termination Criteria:
- Voluntary withdrawal from the study or discontinuation for any other reason;
- Poor compliance, defined as failure to follow instructions or complete assigned tasks as required by the protocol;
- Experiencing severe exercise intolerance or adverse reactions to the intervention.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Step frequency group 1
Participants will receive step frequency in the following order: First test: 162 steps per minute; Second test: 180 steps per minute; Third test: 198 steps per minute. |
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
|
|
Experimental: Step frequency group 2
Participants will receive step frequency in the following order: First test: 162 steps per minute; Second test: 198 steps per minute; Third test: 180 steps per minute. |
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
|
|
Experimental: Step frequency group 3
Participants will receive step frequency in the following order: First test: 180 steps per minute; Second test: 162 steps per minute; Third test: 198 steps per minute.
|
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
|
|
Experimental: Step frequency group 4
Participants will receive step frequency in the following order: First test: 180 steps per minute; Second test: 198 steps per minute; Third test: 162 steps per minute. |
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
|
|
Experimental: Step frequency group 5
Participants will receive step frequency in the following order: First test: 198 steps per minute; Second test: 162 steps per minute; Third test: 180 steps per minute. |
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
|
|
Experimental: Step frequency group 6
Participants will receive step frequency in the following order: First test: 198 steps per minute; Second test: 180 steps per minute; Third test: 162 steps per minute. |
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
162 steps per minute crossover to 180 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
180 steps per minute crossover to 162 steps per minute and 198 steps per minute.
The exercise protocol lasted 21 minutes, comprising a 10-minute period of slow-pace running, preceded by a 3-minute quiet resting period and a 3-minute warm-up, and followed by a 5-minute recovery period after the warm-up and slow-pace running.
198 steps per minute crossover to 162 steps per minute and 180 steps per minute.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Resting Energy Expenditure (REE)
Time Frame: Baseline
|
Subjects abstained from strenuous activity, substances (medication/alcohol/caffeine), and smoking 24h pre-test; females avoided menstruation.
Post 12h fast/sleep, subjects rested seated 15min.
Resting HR measured (Polar RS400).
Subjects fitted with cardiopulmonary telemetry (Cortex Metamax 3B), positioned supine.
Maintained steady breathing, upward gaze, minimal movement.
HR/V̇O₂ monitored until stabilization.
10min data collection; steady state = <5% V̇O₂ fluctuation over 5min.
|
Baseline
|
|
Energy Expenditure at Step Frequencies
Time Frame: through study completion, an average of 4 weeks
|
Telemetry/HR monitor worn for 3min warm-up.
First test: 10min treadmill run (5 km/h) with HR/V̇O₂ recording.
Two subsequent sessions followed.
Randomized crossover prevented order effects: subjects drew lots for step frequency sequence (162, 180, 198 steps/min).
Metronome ensured adherence.
|
through study completion, an average of 4 weeks
|
|
Heart rate
Time Frame: through study completion, an average of 4 weeks
|
Upon entering the laboratory, subjects wore a heart rate telemetry monitor (RS400 Polar, Finland) and rested seated for 15 minutes to obtain resting heart rate.
Following warm-up, subjects commenced testing.
A heart rate monitor was secured on the right wrist pre-exercise to continuously monitor heart rate during activity.
|
through study completion, an average of 4 weeks
|
|
Electromyographic indicators
Time Frame: through study completion, an average of 4 weeks
|
Wireless surface EMG data were acquired using the Trigno system (Delsys®, USA) at 2000 Hz.
Electrodes were positioned at the mid-belly of each muscle parallel to the muscle fiber orientation.
Signals were recorded from the:Biceps femoris、Rectus femoris、Tibialis anterior、Lateral gastrocnemius、Medial gastrocnemius.
EMGworks Analysis® software (Delsys) processed raw signals.
|
through study completion, an average of 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-Exercise Oxygen Consumption (EPOC)
Time Frame: through study completion, an average of 4 weeks
|
EPOC was calculated from pre-/post-exercise oxygen consumption (O₂PRE/O₂POST) measured via portable cardiopulmonary telemetry (Cortex Metamax 3B): EPOC (L) = O₂POST (L) - O₂PRE (L) where: EPOC denotes excess post-exercise oxygen consumption, O₂POST represents post-exercise oxygen consumption, and O₂PRE represents pre-exercise oxygen consumption.
|
through study completion, an average of 4 weeks
|
|
Fat Oxidation
Time Frame: through study completion, an average of 4 weeks
|
Fat Oxidation Data were collected and analyzed using the portable cardiopulmonary telemetry system (Cortex Metamax 3B, Germany).
The fat oxidation rate was calculated as follows: Fat oxidation rate (g/min) = ② Fat Oxidation Fat oxidation rate was derived as: 1.695 × V̇O₂ (L/min) - 1.701 × V̇CO₂ (L/min) (g/min) using mean V̇O₂/V̇CO₂ from final 2min of each stage.
③ Carbohydrate Oxidation Carbohydrate oxidation rate was calculated as: 4.585 × V̇CO₂ (L/min) - 3.226 × V̇O₂ (L/min) (g/min) using mean V̇O₂/V̇CO₂ from final 2min of each stage.
All data collected/analyzed with Cortex Metamax 3B system.
|
through study completion, an average of 4 weeks
|
|
Carbohydrate Oxidation
Time Frame: through study completion, an average of 4 weeks
|
Carbohydrate oxidation rate was calculated as: 4.585 × V̇CO₂ (L/min) - 3.226 × V̇O₂ (L/min) (g/min) using mean V̇O₂/V̇CO₂ from final 2min of each stage.
All data collected/analyzed with Cortex Metamax 3B system.
|
through study completion, an average of 4 weeks
|
|
RPE
Time Frame: through study completion, an average of 4 weeks
|
Immediately after each exercise stage, subjects rated perceived exertion using the Borg RPE scale.
The 15-point scale (6-20; 6 = no exertion, 20 = maximal exertion) was administered and recorded post-stage.
|
through study completion, an average of 4 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2025-0505
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Energy Expenditure
-
Hospices Civils de LyonCompleted
-
University of South CarolinaCompleted
-
Catholic University of BrasíliaCompletedEnergy Expenditure
-
Clinical Nutrition Research Centre, SingaporeCompletedEnergy ExpenditureSingapore
-
Institut National de Recherche pour l'Agriculture...Centre de Recherche en Nutrition Humaine Rhone-Alpe; Centre de Recherche en...CompletedEnergy Expenditure | Computer Simulation | Energy MetabolismFrance
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling by invitation
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Pennington Biomedical Research CenterCompletedEnergy ExpenditureUnited States
-
American University of Beirut Medical CenterUnknownEnergy ExpenditureLebanon
-
Ori Diagnostic Instruments LLCSuspendedBody Composition | Energy Expenditure | Energy Metabolism | Body FluidsUnited States
Clinical Trials on 162 step frequency
-
Donders Centre for Cognitive NeuroimagingParkinson's FoundationCompleted
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
Vanda PharmaceuticalsCompleted
-
Vanda PharmaceuticalsCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingHaematological Malignancies | SarcomasItaly
-
Vanda PharmaceuticalsActive, not recruitingNon 24 Hour Sleep Wake DisorderFrance
-
Cancer Institute and Hospital, Chinese Academy...Beijing Shenogen Biomedical Co., LtdCompleted
-
Vanda PharmaceuticalsCompletedNon-24-Hour Sleep-Wake DisorderUnited States
-
Vanda PharmaceuticalsCompleted
-
Vanda PharmaceuticalsCompletedNon-24-Hour Sleep-Wake DisorderUnited States, Germany